Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
about
Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical PracticeOrgan-specific responses to circulatory disturbances in heart failure: new insightsThe kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'Cardiorenal syndrome: a cardiologist's perspective of pathophysiologyManagement of the cardiorenal syndrome in decompensated heart failureCardio-renal syndromeEffects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failureAdenosine receptors and the kidneyThe feasibility of a telephone coaching program on heart failure home management for family caregivers.Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure.Effect of renal function on prognosis in chronic heart failure.Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI RegistryAssociation between human resources and risk of hospitalisation in end-stage renal disease outpatients receiving haemodialysis: a longitudinal cohort study using claim data during 2013-2014.Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trialRelevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiativeSerum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.Early adverse events as predictors of 1-year mortality during mechanical circulatory support.Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: insight from the acute decompensated heart failure syndromes (ATTEND) registryNeutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study.Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward.Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations.A patient with heart failure and worsening kidney functionAcute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes.The cardiorenal syndrome: making the connection.Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactionsThe risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan.Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure.Cardiorenal syndromes: pathophysiology to preventionCharacteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure.The growth of acute kidney injury: a rising tide or just closer attention to detail?Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization.The cardiorenal syndrome: a reviewPotential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.Cardiorenal syndromes.Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trialAcute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitideAssociation between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.
P2860
Q26772195-133D87F8-E914-48A0-AF0E-13D288CFB174Q26822738-80D160C0-5E47-4670-BB91-FB03FBE54F82Q27011043-A5C8A728-7855-42BD-A36A-A39398FB7A86Q27023089-FDF48D43-58CD-4B5B-A72E-9F1569D04719Q27028203-64175699-22E1-464E-B201-6180AF7F4865Q28067064-FC3E9A46-EDBD-4D0E-A267-0FA42D5B9504Q28212766-31B6CD07-6674-4E5C-89FA-B947DF21983DQ28253255-E578D66B-6FB3-4F7F-9BF4-E3F509E8296BQ30223904-65BAF738-0F05-47CF-9140-EAECF3A9B294Q30315923-B636981A-D5A7-4743-8FA2-277F5F538465Q30361766-76737F0F-E3BE-4BF1-81F0-2C017EB6F390Q30878953-F008238A-A2B9-4AD7-9C9A-1AA52CE4006FQ31122131-FD982457-27F2-45C3-8ABE-9D69B9887DCCQ33566655-A7FCD0AA-DF81-44BA-8A7C-8646C777A2E7Q33698744-21074764-3457-42AF-A864-B111F98FFD9EQ33728260-0B851B58-674C-43A4-8B93-4573E2F5DED2Q33799444-04DC7C05-8A46-491E-A75F-CF813C8ADD15Q33799478-ED4EB9C3-D788-4837-B613-C9CF0E5B8C77Q33964843-E45D538D-BC68-448A-84F4-376EAAFA1806Q34079591-901F29CA-4C35-4797-A960-0CF7920A0AB3Q34149704-BDB5AFFF-7AD6-4569-B782-0EDA3A82A438Q34160755-F98677B2-E122-46C6-9D07-DD4825CA9660Q34181036-D8CDD3BA-6473-40E7-A7D4-FBBDF3CBF2F2Q34264037-8C067A96-1C7B-48FB-A088-FC13ABB6A57BQ34292920-D6280101-8599-422B-BEC5-5CA6C327BF24Q34322180-5ED48D9B-C9E3-46B3-89D3-B9FEE9DE5AD0Q34340391-1372504F-DB16-4AF2-B494-6F3343B58643Q34354535-D70D88D0-26C8-474E-BA4E-2332CF9406A7Q34366134-80A6ACBE-AF99-4696-AF2C-8B6DAFDA2AE8Q34372498-CC47C976-D0C6-43EA-A45D-B26D52DE1CBEQ34373061-48E28CC2-A6E3-4C0F-B502-DEF07FA0B4DCQ34380235-6728A925-CC75-4F4F-9AB4-A98396C3C063Q34439098-A9713F7E-0F29-4D4C-B75F-0261699A25AAQ34470304-D7380BBA-2CA0-4E48-A644-EC89056EC76FQ34495307-151FA3EC-D735-4F3B-B424-7BE8F0B17412Q34512319-D06ED20B-94F5-4035-9BD3-4AF489FE695BQ34538721-ABCCB839-5C8B-4583-8666-8AA9CA09263BQ34570220-A8FB24EB-9B71-44D4-9945-F71869172250Q34643664-86073CEE-D206-4630-A14F-28C3E93176A1Q34765857-09954B7C-89BF-4CD6-BF28-020FE1765CB3
P2860
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Incidence, predictors at admis ...... spitalized with heart failure.
@ast
Incidence, predictors at admis ...... spitalized with heart failure.
@en
type
label
Incidence, predictors at admis ...... spitalized with heart failure.
@ast
Incidence, predictors at admis ...... spitalized with heart failure.
@en
prefLabel
Incidence, predictors at admis ...... spitalized with heart failure.
@ast
Incidence, predictors at admis ...... spitalized with heart failure.
@en
P2093
P50
P1476
Incidence, predictors at admis ...... spitalized with heart failure.
@en
P2093
Barry M Massie
Daniel E Forman
James B Young
Lynne Warner Stevenson
Michael W Rich
Stephen S Gottlieb
William T Abraham
Yongfei Wang
P356
10.1016/J.JACC.2003.07.031
P407
P577
2004-01-01T00:00:00Z